OTC Healthcare in Nigeria

Euromonitor International's OTC Healthcare in Nigeria market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Why buy this report

• Get insight into trends in market performance
• Pinpoint growth sectors and identify factors driving change
• Identify market and brand leaders and understand the competitive environment

Product coverage

Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments

Executive summary

OTC healthcare remains vibrant in 2007

The OTC healthcare market is the largest and most vibrant for medical products in Nigeria, and experienced strong, steady growth over the period under review. This growth was stimulated by self-medication, which is the leading form of healthcare among the majority of Nigerians given the problems and expense of visiting a doctor. The market has also benefited from improved regulatory activities by the National Agency for Food and Drug Administration and Control (NAFDAC). Government policies and spending on healthcare positively impacted the market. Advertising and marketing activities of key players also contributed to growth.

The war against fake drugs

NAFDAC’s war on drug counterfeiters saw some success over the last four years. As a result, the incidence of counterfeit drugs has declined by around 40% in the country. Prior to 2001, NAFDAC saw little success in combating drug counterfeiters. However, despite NAFDAC’s best efforts, fake drugs remain a major issue affecting the growth and value of OTC healthcare in Nigeria. The lack of a standardised distribution network is one of the factors contributing to the high incidence of fake drugs.

Highly fragmented market, intense competition

The competitive environment for OTC healthcare in Nigeria is highly fragmented, with a large number of players. There are over 200 existing local pharmaceutical manufacturers that meet an estimated 40% of demand for OTC drugs. A large proportion of OTC drug imports come from India, China and Pakistan. At the end of the review period no company held a value share of over 6%.

Distribution of drugs largely unstructured

The drug distribution network in Nigeria is largely unstructured. It consists of open markets, drugstores, pharmacies, private and public hospitals, wholesalers/importers and pharmaceutical manufacturers. It is common in Nigeria to see petty traders selling kola nuts, cigarettes and oranges, among other items through kiosks, motor parks, and roadside establishments, hawking medical products ranging from OTC drugs to antibiotics. A major source of substandard and counterfeit drugs in Nigeria is the large number of unregulated drug markets in major cities. In order to sanitize drug distribution channels, NAFDAC has proposed the concept of Zonal Drug Distribution Centres in the six geo-political zones of the country. The Zonal Drug Distribution Centres will result in a total revolution in the Nigerian drug distribution system.

Strong growth is expected to continue

The OTC healthcare market is projected to continue to see strong and steady growth over the forecast period. Increased health consciousness and expected economic and political stability in Nigeria will drive growth. Growth will also be stimulated by an expected increase in government spending on healthcare, company advertising and keen competition among the key players. The ageing population and increased health awareness among consumers will result in the growth of products such as analgesics.

Table of contents

OTC HEALTHCARE IN NIGERIA : MARKET INSIGHT

EXECUTIVE SUMMARY

OTC healthcare remains vibrant in 2007

The war against fake drugs

Highly fragmented market, intense competition

Distribution of drugs largely unstructured

Strong growth is expected to continue

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007

Table 2 Life Expectancy at Birth 2002-2007

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007

Table 5 OTC Healthcare Company Shares by Value 2003-2007

Table 6 OTC Healthcare Brand Shares by Value 2004-2007

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012

APPENDIX

OTC Registration and Classification

Advertising

Packaging and Labelling

Distribution

Vitamins & Dietary Supplements Registration and Classification

Generics

Switches

DEFINITIONS

Summary 1 Research Sources

MAY & BAKER NIGERIA PLC

Strategic Direction

Key Facts

Summary 2 May & Baker Nigeria Plc: Key Facts

Summary 3 May & Baker Nigeria Plc: Operational Indicators

Company Background

Production

Summary 4 May & Baker Nigeria Plc: Production Statistics 2007

Competitive Positioning

Summary 5 May & Baker Nigeria Plc: Competitive Position 2007

NEIMETH INTERNATIONAL PHARMACEUTICALS PLC

Strategic Direction

Key Facts

Summary 6 Neimeth International Pharmaceuticals Plc: Key Facts

Summary 7 Neimeth International Pharmaceuticals Plc: Operational Indicators

Company Background

Production

Summary 8 Neimeth International Pharmaceuticals Plc: Production Statistics 2007

Competitive Positioning

Summary 9 Neimeth International Pharmaceuticals Plc: Competitive Position 2007

NIGERIAN-GERMAN CHEMICALS PLC

Strategic Direction

Key Facts

Summary 10 Nigerian-German Chemicals Plc: Key Facts

Summary 11 Nigerian-German Chemicals Plc: Operational Indicators

Company Background

Production

Summary 12 Nigerian-German Chemicals Plc: Production Statistics 2007

Competitive Positioning

Summary 13 Nigerian-German Chemicals Plc: Competitive Position 2007

ANALGESICS IN NIGERIA

Headlines

Trends

switches

Competitive Landscape

Prospects

Sector Data

Table 11 Sales of Analgesics by Subsector: Value 2002-2007

Table 12 Sales of Analgesics by Subsector: % Value Growth 2002-2007

Table 13 Analgesics Company Shares by Value 2003-2007

Table 14 Analgesics Brand Shares by Value 2004-2007

Table 15 Forecast Sales of Analgesics by Subsector: Value 2007-2012

Table 16 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NIGERIA

Headlines

Trends

switches

Competitive Landscape

Prospects

Sector Data

Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007

Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007

Table 19 Sales of Decongestants by Type: Value 2002-2007

Table 20 Sales of Decongestants by Type: % Value Growth 2002-2007

Table 21 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007

Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007

Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007

Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007

Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012

Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012

DIGESTIVE REMEDIES IN NIGERIA

Headlines

Trends

switches

Competitive Landscape

Prospects

Sector Data

Table 27 Sales of Digestive Remedies by Subsector: Value 2002-2007

Table 28 Sales of Digestive Remedies by Subsector: % Value Growth 2002-2007

Table 29 Digestive Remedies Company Shares by Value 2003-2007

Table 30 Digestive Remedies Brand Shares by Value 2004-2007

Table 31 Forecast Sales of Digestive Remedies by Subsector: Value 2007-2012

Table 32 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2007-2012

MEDICATED SKIN CARE IN NIGERIA

Headlines

Trends

switches

Competitive Landscape

Prospects

Sector Data

Table 33 Sales of Medicated Skin Care by Subsector: Value 2002-2007

Table 34 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007

Table 35 Medicated Skin Care Company Shares by Value 2003-2007

Table 36 Medicated Skin Care Brand Shares by Value 2004-2007

Table 37 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012

Table 38 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012

VITAMINS AND DIETARY SUPPLEMENTS IN NIGERIA

Headlines

Trends

Competitive Landscape

Prospects

Sector Data

Table 39 Sales of Vitamins and Dietary Supplements by Subsector: Value 2002-2007

Table 40 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2002-2007

Table 41 Sales of Vitamins by Type: Value 2002-2007

Table 42 Sales of Vitamins by Type: % Value Growth 2002-2007

Table 43 Sales of Dietary Supplements by Type: Value 2002-2007

Table 44 Sales of Dietary Supplements by Type: % Value Growth 2002-2007

Table 45 Vitamins and Dietary Supplements Company Shares by Value 2003-2007

Table 46 Vitamins and Dietary Supplements Brand Shares by Value 2004-2007

Table 47 Vitamins Brand Shares by Value 2004-2007

Table 48 Dietary Supplements Brand Shares by Value 2004-2007

Table 49 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2007-2012

Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2007-2012

NRT SMOKING CESSATION AIDS IN NIGERIA

Headlines

SECTOR INDICATORS

Table 51 Number of Smokers by Gender 2002-2007

EYE CARE IN NIGERIA

Headlines

Sector Data

Table 52 Sales of Eye Care by Subsector: Value 2002-2007

Table 53 Sales of Eye Care by Subsector: % Value Growth 2002-2007

Table 54 Eye Care Company Shares by Value 2003-2007

Table 55 Eye Care Brand Shares by Value 2004-2007

Table 56 Forecast Sales of Eye Care by Subsector: Value 2007-2012

Table 57 Forecast Sales of Eye Care by Subsector: % Value Growth 2007-2012

WOUND TREATMENTS IN NIGERIA

Headlines

Sector Data

Table 58 Sales of Wound Treatments by Subsector: Value 2002-2007

Table 59 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007

Table 60 Wound Treatments Company Shares by Value 2003-2007

Table 61 Wound Treatments Brand Shares by Value 2004-2007

Table 62 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012

Table 63 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012

EAR CARE IN NIGERIA

Headlines

Sector Data

Table 64 Sales of Ear Care: Value 2002-2007

Table 65 Sales of Ear Care: % Value Growth 2002-2007

Table 66 Ear Care Company Shares by Value 2003-2007

Table 67 Ear Care Brand Shares by Value 2004-2007

Table 68 Forecast Sales of Ear Care: Value 2007-2012

Table 69 Forecast Sales of Ear Care: % Value Growth 2007-2012

ADULT MOUTH CARE IN NIGERIA

Headlines

Sector Data

Table 70 Sales of Adult Mouth Care: Value 2002-2007

Table 71 Sales of Adult Mouth Care: % Value Growth 2002-2007

Table 72 Adult Mouth Care Company Shares by Value 2003-2007

Table 73 Adult Mouth Care Brand Shares by Value 2004-2007

Table 74 Forecast Sales of Adult Mouth Care: Value 2007-2012

Table 75 Forecast Sales of Adult Mouth Care: % Value Growth 2007-2012

CALMING AND SLEEPING PRODUCTS IN NIGERIA

Headlines

EMERGENCY CONTRACEPTION IN NIGERIA

Headlines

Table 76 Sales of Emergency Contraception by Subsector: Value 2002-2007

Table 77 Sales of Emergency Contraception by Subsector: % Value Growth 2002-2007

Table 78 Forecast Sales of Emergency Contraception by Subsector: Value 2007-2012

Table 79 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2007-2012